Search database
Filter
2763
Text search: WHO drug use indicators
Featured
Language
Document type
1834
401
264
111
96
24
15
12
5
1
Countries
170
107
89
84
84
74
72
61
61
59
59
58
56
55
54
50
48
46
44
40
39
29
28
28
27
26
25
25
23
21
20
17
15
14
14
13
10
10
10
10
9
9
8
8
7
7
7
7
6
6
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
304
162
123
116
93
72
54
46
38
25
23
22
21
19
18
17
17
17
17
16
16
16
15
15
15
14
14
13
13
12
12
11
11
11
10
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1348
178
158
89
66
30
24
1
1
Toolboxes
315
239
184
154
74
67
57
56
52
47
32
29
27
27
19
19
14
13
8
4
4
4
3
 Download
  View PDF
 Add to my MEDBOX

Modelling the health impacts of disruptions to essential health services during COVID-19

UN Children's Fund UNICEF; Umited Nations Popuilation Fund UNFPA; World Health Organization WHO (2021) C_WHO
- Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition Coronavirus disease 2019 (COVID-19) has a wide range of documented effects. It directly causes death and disability for some people infected. However, disruption to ... more
 Download
  View PDF
 Add to my MEDBOX

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ... more
 Download
  View PDF
 Add to my MEDBOX

Health, Rights and Drugs
recommended

UNAIDS (2019) C_WHO
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
 Download
  View PDF
 Add to my MEDBOX

Good Pharmacovigilance Practices for the Americas

Pan American Health Organization (PAHO) (2011) C_WHO
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, ... more
 Download
  View PDF
 Add to my MEDBOX

Global AIDS Monitoring 2018

Joint United Nations Programme on HIVAIDS (UNAIDS) (2018) C1
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of ... more
 External Link
 Add to my MEDBOX

A conceptual framework for the environmental surveillance of antibiotics and antibiotic resistance

Patricia M.C. Huijbers, Carl-Fredrik Flach, D.G. Joakim Larsson Centre for Antibiotic Resistance Research (CARe), University of Gothenburg (2019) C2
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-in ... more
 Download
  View PDF
 Add to my MEDBOX

PIH Guide to the Medical Management of MDR-TB

USAID; TB Care; DRTB Training Network (2014) C1
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
 Download
  View PDF
 Add to my MEDBOX

Essentials For Emergencies

World Health Organization (2004) C_WHO
The purpose of this booklet is to assist WHO and other Public Health workers in the field when an emergency occurs. The booklet provides technical hints on how to carry out a rapid health assessment, how to facilitate coordination, how departmen ... more
 Download
  View PDF
 Add to my MEDBOX

Zimbabwe National Pharmacovigilance Policy Handbook, 2nd ed.

Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care (2016) C2
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance ... more
 Add to my MEDBOX

Democratic Republic of Timor-Leste Ministry of Health - Comprehensive TB Guidelines for National Tuberculosis Program, V Edition

Government of Timor-Leste; World Health Organization (2023) CC
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death. The salient observations are as follows: In 2018, 487 (12.5%) of the ... more
 Add to my MEDBOX

Child Protection

Krishanan, S.; A. Sahoo and R. Goswami Save the Children (2015) CC
The guidebook can be used by any care giver who comes in contact with children on a daily basis and who have the primary or secondary responsibility of taking care of the children. Parents, teachers ... more
 Download
  View PDF
 Add to my MEDBOX

Child Protection - Every Child Safe and Secure (Child protection Guide) - India

Save the Children (2015) C1
The guidebook can be used by any care giver who comes in contact with children on a daily basis and who have the primary or secondary responsibility of taking care of the children. Parents, teachers ... more
 Download
  View PDF
 Add to my MEDBOX

Belgian Antibiotic Policy Coordination Committee Policy paper for the 2014-2019 term

Erica Balligand, Michiel Costers and Evelyne Van Gastel Belgian Antibiotic Policy Coordination Committee (2014) C2
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. ... more
 Download
  View PDF
 Add to my MEDBOX

Regional Strategy on Regulation of Medical Products in the African Region, 2016–2025

World Health Organization, Regional Office for Africa (2016) C_WHO
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis ... more
 Download
  View PDF
 Add to my MEDBOX

PAHO’s Response to Maintaining an Effective Technical Cooperation Agenda in Venezuela and Neighboring Member States, November 2016 to July 2020

Pan American Health Organisation PAHO (2020) C_WHO
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, ... more
 Download
  View PDF
 Add to my MEDBOX

Emergency Triage Assessment and Treatment Plus (ETAT+) - National Training Manual

Reproductive and Child Health Ministry of Health and Sanitation Sierra Leone (2017) CC
The purpose of this reference manual to support learning of ETAT + principles and to complement your clinical training and practice. The manual is for use before, during, and after an ETAT + course. This manual contains the necessary information to ... more
 Download
  View PDF
 Add to my MEDBOX

Psychosocial counselling and treatment adherence support for people affected by tuberculosis

The Union (2021) C1
The guide is suitable and can be used for the following audiences: 1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into ... more
 External Link
 Add to my MEDBOX

The global distribution of lymphatic filariasis, 2000–2018: a geospatial analysis

The Lancet Global Health (2020) C1
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) ... more
 Download
  View PDF
 Add to my MEDBOX

3MDG Maternal, Newborn and Child Health Indicator Guidelines [2nd ed.]

Three Millennium Development Goal Fund (3MDG) (2016) C1
Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health S ... (2014 June, DoPH, MoH), A Guide for Monitoring and Evaluating Child Health Programmes (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated. more
 External Link
 Add to my MEDBOX

Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data

Doubova SV, Leslie HH, Kruk ME, et al. BMJ Global Health (2021) CC
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicte ... more
 Add to my MEDBOX

The State of the World’s Antibiotics Report 2021

Siriam, A.; et al. The Center For Disease Dynamics, Economics & Policy CDDEP (2021) CC
A Global Analysis of Antimicrobial Resistance and Its Drivers. Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic ... more
 Download
  View PDF
 Add to my MEDBOX

Estimating the Size of Populations through a Household Survey (ESPHS) - RWANDA 2011

Rwanda Biomedical CenterInstitute of HIV (2012) C2
This report presents the findings of the Estimating the Size of Populations through a Household Survey (ESPHS) study that took place in 2011. The study utilized a single household survey to estimate the size of several key populations, including sex workers, men ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Myanmar

The Republic of the Union of Myanmar, Ministry of Health, Department of Health, National Tuberculosis Programme (2013) C_WHO
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop ... more
 External Link
 Add to my MEDBOX

Sexual and Reproductive Health and Rights (SRHR) Policy 2017-2022

United Nations Population Fund UNFPA, Ministry of Health Malawi Ministry of Health Malawi (2017) CC
The revision of the SRHR Policy is based on the results of the analysis of the implementation process of the past policy, which has provided evidence to ensure that the revised policy is relevant and effective. The revision has also been done with the participation of all national stakeholders ... more
 Download
  View PDF
 Add to my MEDBOX

Recent Trends in HIV-Related Knowledge and Behaviors in Rwanda, 2005-2010: Further Analysis of the Demographic and Health Surveys.

Hong, Rathavuth, Jean de Dieu, Jeanine Umutesi Condo, Muhayimpundu Ribakare, and Egidie Murekatete Calverton, Maryland, USA: ICF International (2013) C2
DHS Further Analysis Reports No. 89 - The 2010 Rwanda Demographic and Health Survey shows that 3 percent of Rwandan adults age 15-49 have been infected with HIV. The prevalence was much higher in urban areas, among women, and among adults who had mu ... more
 Download
  View PDF
 Add to my MEDBOX

Prevention and Control of Non-Communicable Diseases in Zambia: The Case for Investment

Ministry of Health, Zambia (2020) CC
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of socioeconomic development . The Vision 2030 aims to transform Zambia into a prosperous middle-income country as articulated also in the 7th National De ... more
 Add to my MEDBOX

Guideline for Preventive Chemotherapy for the Control of Taenia solium Taeniasis

Pan American Health Organisation PAHO (2021) C_WHO
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of ... more
 Download
  View PDF
 Add to my MEDBOX

Research and Evaluation Agenda for HIV and Maternal Health in sub-Saharan Africa

Kendall, Tamil; Danel, Isabella (2014) C1
Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp ... more
 External Link
 Add to my MEDBOX

Africa CDC Event-based Surveillance Resources

Africa Center for Disease Control and Prevention (2023) CC
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing event-based surveillance (EBS) using a multisectoral, One Health approach. To ... more
 External Link
 Add to my MEDBOX

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

Schwalm, J.; McKee, M.; Huffman, M. et al. Circulation (2016) CC
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the ... more
 External Link
 Add to my MEDBOX

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... more
 Add to my MEDBOX

Malawi National Communication and Advocacy Strategy for Pre-Exposure Prophylaxis (PrEP)

United States Agency for International Development; President's Emergency Plan for AIDS Relief; National AIDS Commission MAlawi (2022) CC
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasises the role of preexposure prophylaxis (PrEP) in ... more
 Download
  View PDF
 Add to my MEDBOX

Nepal Multiple Indicator Cluster Survey. Key Findings

Central Bureau of Statistics and UNICEF Nepal (2015) C1
MICS surveys measure key indicators that allow countries to generate data for use in policies and programmes, and to monitor progress towards the Millennium Development Goals (MDGs) and other inte ... more
 Download
  View PDF
 Add to my MEDBOX

Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update

Fuchs A., J. Bielickia, S. Mathur, et.al. World Health Organization (2016) C_WHO
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
 Download
  View PDF
 Add to my MEDBOX

Assessment of Impact of Harm Reduction Interventions among People who Inject Drugs (PWID) in Dhaka City

National AIDSSTD Program, Directorate General of Health Services; Ministry of Health and Family Welfare, Govt. of Bangladesh (2014) C1
 Add to my MEDBOX

Promoting the rational use of medicines

USAID; SIAPS (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Rational Use of Medicines: a review

Dutta, S. (2019) CC
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
 Add to my MEDBOX

Nepal: Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users (FIDUs) in Kathmandu Valley Round I –2016, Fact Sheet

National Center for AIDS and STD Control (2016) C1
 External Link
 Add to my MEDBOX

Rationality of drug prescriptions in rural health centres in Burkina Faso

Krause G., M. Borchert, J. Benzler et al. Health policy and planning (1999) C2
Burkina Faso has approximately 10.5 million inhabitants and is divided into 30 provinces. The study took place in the districts of Tougan, Nouna, and Solenzo, in provinces Sourou and Kossi, in north-west Burkina Faso. There is one medical centre in every district capital and 6 to 14 health centres i ... more
 Download
  View PDF
 Add to my MEDBOX

Serbia National Drug Report 2017

European Monitoring Centre for Drugs and Drug Addiction; Republic of Serbia Ministry of Health (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Antimalarial drug policy for Ghana

Ministry of Health Ghana (2009) C1
Revised Edition
 Download
  View PDF
 Add to my MEDBOX

Frequently asked questions on the WHO treatment guidelines for isoniazid-resistant tuberculosis

World Health Organization WHO (2018) C_WHO
Version: 24 April 2018
 Download
  View PDF
 Add to my MEDBOX

Preventive chemotherapy in human helminthiasis : coordinated use of anthelminthic drugs in control

World Health Organization (2006) C_WHO
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
 Download
  View PDF
 Add to my MEDBOX

WHO Recommended Surveillance Standards Malaria

World Health Organization (2000)
 Download
  View PDF
 Add to my MEDBOX

Guidelines on the public health response to pretreatment HIV drug resistance

A. Lycett; D. Breuer; F. Verde; et al. World Health Organization (2017) C_WHO
Guidelines HIV drug resistance July 2017
 Download
  View PDF
 Add to my MEDBOX

A WHO / The Union Monograph on TB and Tobacco Control

International Union Against Tuberculosis and Lung Disease, World Health Organization (2007) C_WHO
Joining efforts to control two trelated global epidemics.
 Download
  View PDF
 Add to my MEDBOX

THE NATIONAL PROTOCOL FOR TREATMENT OF SUBSTANCE USE DISORDERS IN KENYA

Ministry of Health, Republic of Kenya (2017) C2
 Add to my MEDBOX

The Pursuit of Responsible Use of Medicines

Sharing and Learning from Country Experiences (2012) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Albania National Drug Report 2017

European Monitoring Centre for Drugs and Drug Addiction; Instituti Shendetit Public European Monitoring Centre for Drugs and Drug Addiction; Instituti Shendetit Public (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWID- Male) in Western to Far Western Terai Highway Districts of Nepal, Round V, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1
 Download
  View PDF
 Add to my MEDBOX

WHO assessment of tuberculosis prevention, control and care in Kazakhstan

M. van der Boom, S. Talevski World Health Organization Europe (2016) C_WHO
17–24 November 2015
 Download
  View PDF
 Add to my MEDBOX

The Global Drug Policy Index 2021

Global Commission on Drug Policy (2021) CC
The power of the Global Drug Policy Index lies in its key objective: to score and rank how countries are faring in different areas of drug policy as identified in the UN report ‘What we have lea ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia 

World Health Organzation WHO WHO Neglected Tropical Diseases Department (2022) C_WHO
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited a ... more
 Add to my MEDBOX

WHO recommendations for prevention and treatment of maternal peripartum infections

World Health Organization WHO (2015) C_WHO
 Add to my MEDBOX

WHO Country Cooperation Strategy Nepal, 2013-2017

World Health Organisation (WHO) Country Office for Nepal (2013) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Management of drug-resistant tuberculosis

World Health Organization (2014) C_WHO
Training for staff working at DR-TB management centres. Training modules
 Download
  View PDF
 Add to my MEDBOX

Global Action Plan on HIV Drug Resistance: Response to comments & modifications

World Health Organization (2016) C_WHO
12-13 December 2016 Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
 Download
  View PDF
 Add to my MEDBOX

Global overview of drug demand and supply - Latest trends, cross-cutting issues

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -2-
 Download
  View PDF
 Add to my MEDBOX

Meeting Report ECDC/WHO Joint Meeting on European HIV/AIDS Surveillance 10-11 March 2016, Bratislava

ECDC European Center for disease prevention and control; World Health Organization (Europe); EACS European AIDS Clinical Society (2019) C2
Accessed: 20.11.2019
 Download
  View PDF
 Add to my MEDBOX

WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses

World Health Organization (2012)
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy- ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Recommended Surveillance Standards

World Health Organization (1999)
Second editon
 Add to my MEDBOX

Building Local Coalitions for containing drug resistance: A guide

USAID, Strengthening Pharmaceutical Systems SPS (2011) C1
 Download
  View PDF
 Add to my MEDBOX

First Bangladesh National Tuberculosis Drug Resistance Survey 2010-2011

Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme (2013) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Cascade Data Use Manual to Identify Gaps in HIV and Health Services for Programme Improvement

World Health Organization (Europe) World Health Organization (Europe) (2018) C_WHO
Use Manual June 2018
 Download
  View PDF
 Add to my MEDBOX

Guidelines for surveillance of drug resistance in tuberculosis

World Health Organization (2021) C_WHO
6th edition
 Download
  View PDF
 Add to my MEDBOX

WHO mission on ART optimization in Belarus March 30-31, April 1, 2016

M. Ristola; V. Rusovich; J. Lundgren; S. F. Jakobsen World Health Organization (Europe); WHO Collaborating Centre on HIV and Viral Hepatitis (2016) C2
April, 2016
 Download
  View PDF
 Add to my MEDBOX

Antimicrobial Use and Resistance in Nigeria

Federal Ministries of Agriculture, Environment and Health (2017) C2
SITUATION ANALYSIS AND RECOMMENDATIONS
 Download
  View PDF
 Add to my MEDBOX

The drug problem and organized crime, illicit financial flows, corruption and terrorism

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -5- Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Analysis of drug markets - Opiates, cocaine, cannabis, synthetic drugs

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -3-
 Download
  View PDF
 Add to my MEDBOX

EU Drug Markets Report

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Strategic Overview
 Download
  View PDF
 Add to my MEDBOX

G2 Substance Use Disorders: Cannabis Use and Misuse

Alan J Budney & Catherine Stanger IACAPAP (2015) C1
 Download
  View PDF
 Add to my MEDBOX

WHO implementation tool for monitoring the toxicity of new antiretroviral and antiviral medicines in HIV and viral hepatitis programmes

World Health Organization WHO (2018) C_WHO
 Add to my MEDBOX

Strategic plan towards ending TB in the WHO South-East Asia Region: 2021–2025

World Health Organization (WHO), Regional Office for South-East Asia (2021) C_WHO
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization ( ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda National Communication Strategy for Promoting Rational Use of Medicines

Federal Ministry of Health, Uganda (2009) C1
 Download
  View PDF
 Add to my MEDBOX

WHO Country Cooperation Strategy 2008-2011

World Health Organization WHO, Regional Office for Africa (2009) C_WHO
 Add to my MEDBOX

WHO Country Cooperation Strategy 2008-2013 Malawi

World Health Organization (2009) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO Country Cooperation Strategy Uganda 2016-2020

World Health Organization (WHO) (2015) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment

World Health Organization WHO (2020) C_WHO
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guideli ... more
 Download
  View PDF
 Add to my MEDBOX

Active tuberculosis drug-safety monitoring and management (aDSM)

World Health Organization (2015) C_WHO
Framework for implementation. The END TB Strategy.
 Download
  View PDF
 Add to my MEDBOX

Framework of Indicators and Targets for laboratory strengthening under the end tb strategy

World Health Organization (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Policy Implementation Package for new TB drug introduction (Russian version)

World Health Organization Europe Всемирная организация здравоохранения (2014) C_WHO
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
 Download
  View PDF
 Add to my MEDBOX

WHO guidance for contingency planning
recommended

World Health Organization (WHO) (2018) C_WHO
In this contingency planning guidance, a set of actions to prepare for emergencies from all hazards and to help minimize their impact, is proposed. These actions include the development, implementation, simulation, monitoring and regular update of risks-based contingency plans.
 Download
  View PDF
 Add to my MEDBOX

WHO Report on Surveillance of Antibiotic Consumption

World Health Organization WHO (2018) C_WHO
2016-2018 Early implementation, This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization ( ... more
 Download
  View PDF
 Add to my MEDBOX

Situation Analysis Antibiotic Use and Resistance in India

Public Health Foundation India (2011) C2
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Eritrea 2022 Annual Report

World Health Organisation (WHO) (2023) C_WHO
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National h ... more
 Download
  View PDF
 Add to my MEDBOX

WHO operational handbook on tuberculosis: Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update
recommended

World Health Organization WHO (2021) C_WHO
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included. The latest operational handbook includes the new classes recommended by WHO. It aims at facil ... more
 Download
  View PDF
 Add to my MEDBOX

WHO COVID-19 prison surveillance protocol: monitoring and reporting COVID-19 in prisons and other places of detention

World Health Organization WHO (2021) C_WHO
This protocol establishes the principles and definitions of a surveillance system devised by the WHO Health in Prisons Programme (‎HIPP)‎ to monitor the evolution of COVID-19-related epidemiological data in prisons and other places of detention ... more
 Add to my MEDBOX

WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance

World Health Organisation (WHO) (2021) C_WHO
In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national action plans that address the five objectives of the World Health Organization Global Action Plan (GAP) by ... more
 Add to my MEDBOX

WHO Good Governance for Medicines programme. an innovative approach to prevent corruption in the pharmaceutical sector

Baghdadi-Sabeti , G.; and F. Serhan World Health Organization WHO (2010) C_WHO
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
 Download
  View PDF
 Add to my MEDBOX

WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector

World Health Organization WHO (2022) C_WHO
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cos ... more
 Add to my MEDBOX

Country cooperation strategy for WHO and Syrian Arab Republic: 2022-2025

World Health Organization WHO (2024) C_WHO
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situatio ... more
 Add to my MEDBOX

WHO operational handbook on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition

World Health Organisation (WHO) (2024) C_WHO
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im ... more
 Download
  View PDF
 Add to my MEDBOX

Bosnia and Herzegovina - National Drug Situation Report 2017

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
 Add to my MEDBOX

Compendium of good practices in the health sector response to HIV in the WHO European Region

Dr. M. Dara; Z. T. Gavry; M. Mansfeld World Health Organization (Europe) (2018) C_WHO
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2019 Booklet 1 Executive summary / Policy implications

United Nations Office on Drug and Crime UNODOC (2022) C1
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe ... more
 Download
  View PDF
 Add to my MEDBOX

UNODC-WHO Stop-Overdose-Safely (‎S-O-S)‎ project implementation in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine

World Health Organization WHO; United Nations Office on Drugs and Crime UNODC (2021) C_WHO
Summary Report
 Download
  View PDF
 Add to my MEDBOX

WHO policy on collaborative TB/HIV activities (Guidelines)

World Health Organization WHO (2012) C_WHO
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
 External Link
 Add to my MEDBOX

WHO checklist for influenza pandemic preparedness planning

World Health Organization (2005) C_WHO
The aim of the pandemic preparedness checklist is primarily to provide an outline of the essential minimum elements of preparedness, as well as elements of preparedness that are considered desirable. It is recommended that responsible authorities or institutes in countries that are in the process of ... more
 Download
  View PDF
 Add to my MEDBOX

Report on the status of major health risk factors for noncommunicable diseases: WHO African Region, 2015

World Health Organization; Africa Region (2016) C_WHO
The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be responsible for over 44 million deaths during the next decade, representing an increase of about 15% sinc ... more